Abstract Details

Title A Phase I Dose-Escalating Study of AAV1-Gamma-Sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 001

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Olivier Benveniste, MD, PhD (Hôpital Pitié-Salpêtrière)	No disclosure on file
Oana M. Dumitrascu, MD, FAAN (Mayo Clinic)	Dr. Dumitrascu has nothing to disclose.
Faycal Hentati, MD	No disclosure on file
Bruno Eymard, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file